ebola
viru
ebov
outbreak
largest
date
west
african
countri
frieden
et
al
hampton
spread
direct
contact
infect
individu
touch
blood
organ
bodili
secret
fluid
contamin
cloth
peopl
macneil
rollin
initi
symptom
ebolaviru
infect
confus
febril
ill
endem
malaria
chertow
et
al
infect
detect
rapidli
patient
live
remot
area
world
health
organ
number
infect
peopl
death
highest
yet
record
control
infect
prevent
transmiss
outbreak
filovirus
ebov
rapid
detect
therefor
essenti
grolla
et
al
current
method
detect
diagnosi
ebov
infect
includ
viru
isol
electron
microscopi
immunohistochemistri
zaki
et
al
enzymelink
immunosorb
assay
test
niikura
et
al
revers
transcriptionpolymeras
chain
reaction
rtpcr
serolog
test
igmigg
virusspecif
antibodi
ksiazek
et
al
saijo
et
al
pointofcar
biosensor
baca
et
al
gener
ebov
viral
load
blood
get
higher
case
fatal
rate
detect
antigen
suitabl
method
use
laboratori
diagnosi
fisherhoch
et
al
ksiazek
et
al
thu
world
health
organ
recommend
realtim
rtpcr
first
choic
ebov
diagnosi
howev
inhibitor
present
crude
biolog
sampl
inactiv
taq
dna
polymeras
use
pcrbase
techniqu
de
franchi
et
al
moreov
method
rel
complex
requir
special
instrument
thu
complement
pcrbase
method
anoth
rapid
simpl
effect
assay
need
loopmedi
isotherm
amplif
lamp
onestep
nucleic
acid
detect
method
develop
notomi
et
al
reli
autocycl
strand
displac
dna
synthesi
novel
method
highli
specif
sensit
take
advantag
four
six
specif
primer
recogn
six
eight
differ
sequenc
target
gene
perform
isotherm
condit
less
h
use
bst
dna
polymeras
furthermor
lamp
less
influenc
inhibitor
present
complex
sampl
standard
pcr
highli
benefici
clinic
specimen
blood
compon
sputum
fece
bodi
fluid
kaneko
et
al
lamp
assay
wide
appli
genet
diagnos
detect
epidem
bacteria
harakudo
et
al
song
et
al
virus
okafuji
et
al
fetal
sex
identif
hirayama
et
al
parasit
recognit
chen
et
al
kong
et
al
kurosaki
et
al
develop
simpl
revers
transcript
loopmedi
isotherm
amplif
rtlamp
assay
detect
zair
ebolaviru
target
trailer
region
viral
genom
howev
method
yet
test
clinic
sampl
ebov
genom
approxim
kb
encod
follow
seven
gene
flank
untransl
region
nucleoprotein
np
viral
structur
protein
vsp
glycoprotein
rnadepend
rna
polymeras
ali
islam
np
highli
conserv
among
ebov
speci
current
known
play
import
role
intracellular
event
replic
transcript
viral
genom
nucleocapsid
format
ali
islam
therefor
recommend
world
health
organ
use
target
gene
rtpcr
assay
present
work
develop
pointofcar
rtlamp
assay
target
np
five
set
primer
detect
ebov
design
use
optim
rtlamp
assay
also
evalu
specif
sensit
lamp
method
final
blood
sampl
collect
patient
clinic
suspect
infect
analyz
rtlamp
rtpcr
clinic
diagnosi
twentysix
genom
respiratori
pathogen
includ
artifici
rna
sudan
ebov
subtyp
sudan
strain
gulu
zair
ebov
marv
sar
coronaviru
influenza
human
parainfluenza
virus
piv
type
adenovirus
adv
serotyp
serotyp
serotyp
respiratori
syncyti
viru
infect
rsvarsvb
mer
rna
human
metapneumoviru
hmpv
human
coronaviru
bocaviru
bov
well
three
respiratori
bacteri
pathogen
legionella
pneumophila
mycobacterium
tuberculosi
haemophilu
influenza
atcc
use
studi
total
viral
rna
extract
cultur
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
infecti
materi
handl
biosafeti
level
facil
prepar
artifici
ebov
rna
perform
describ
previous
watanab
et
al
modif
briefli
kb
np
fragment
synthes
sangon
biotech
co
ltd
shanghai
china
clone
vector
invers
orient
promot
sequenc
promega
vitro
transcript
artifici
ebov
rna
np
subclon
carri
use
u
rna
polymeras
promega
reaction
volum
accord
manufactur
instruct
rna
concentr
determin
measur
optic
densiti
nm
rna
puriti
determin
calcul
absorpt
ratio
ratio
ensur
rna
dissolv
depctreat
water
store
use
base
np
sequenc
strain
mayinga
deposit
genbank
access
select
potenti
target
region
analyz
sequenc
use
primer
explor
align
speci
ebov
design
specif
primer
set
detect
ebo
v
rtlamp
set
includ
outer
forward
primer
outer
backward
primer
forward
inner
primer
fip
backward
inner
primer
bip
link
four
thymidin
spacer
tttt
recogn
sens
antisens
strand
acceler
rtlamp
reaction
addit
loop
primer
lb
design
primer
synthes
commerci
sangon
biotech
co
ltd
revers
transcript
loopmedi
isotherm
amplif
reaction
perform
use
loopamp
rna
amplif
kit
eiken
chemic
co
ltd
tokyo
japan
volum
accord
manufactur
protocol
reaction
includ
pmol
fip
bip
pmol
lb
pmol
templat
rna
reaction
carri
min
dri
bath
incub
revers
transcript
loopmedi
isotherm
amplif
amplifi
product
detect
turbid
monitor
well
visual
observ
assess
turbid
amount
white
magnesium
phosphat
precipit
produc
lamp
reaction
process
monitor
use
loopamp
realtim
turbidimet
eiken
chemic
co
ltd
tochigi
japan
record
reaction
curv
nm
everi
magnesium
ion
reaction
buffer
mori
et
al
visual
inspect
tube
contain
fluoresc
calcein
observ
nake
eye
photograph
natur
light
uv
light
nm
color
chang
orang
green
posit
reaction
neg
control
remain
orang
illustr
rtlamp
detect
sensit
target
region
np
use
liferivertm
ebov
real
time
rtpcr
kit
shanghai
zj
biotech
co
ltd
recommend
world
health
organ
thermocycl
condit
follow
manufactur
instruct
amplif
process
fluoresc
intens
report
dye
fam
quencher
dye
tamra
record
calcul
normal
report
signal
link
amount
product
amplifi
standard
curv
drawn
use
vitro
transcrib
rna
standard
calcul
number
rna
copi
viral
rna
extract
threshold
cycl
ct
valu
refer
number
amplif
cycl
fluoresc
reach
threshold
total
clinic
specimen
whole
blood
swab
collect
patient
thought
infect
ebov
outbreak
sierra
leon
rtlamp
assay
realtim
rtpcr
perform
simultan
china
mobil
laboratori
test
team
freetown
sierra
leon
inform
clinic
sampl
list
supplement
tabl
studi
carri
accord
recommend
institut
diseas
control
prevent
china
written
inform
consent
subject
subject
gave
written
inform
consent
accord
declar
helsinki
total
five
set
primer
initi
design
detect
artifici
ebov
rna
use
realtim
turbidimet
shown
figur
primer
set
amplifi
np
shortest
time
min
chosen
optim
primer
set
rtlamp
detect
ebov
tabl
optim
amplif
compar
reaction
temperatur
rang
interv
suitabl
reaction
temperatur
rang
shown
figur
ultim
chosen
optim
reaction
temperatur
test
lamp
specif
np
test
non
zair
ebov
virus
addit
ebov
vitro
transcrib
artifici
ebov
rna
posit
control
figur
show
ebov
rna
identifi
posit
rtlamp
primer
set
use
turbid
monitor
visual
observ
non
zair
ebov
strain
test
neg
includ
blank
control
indic
rtlamp
method
specif
ebov
determin
sensit
rtlamp
assay
ebov
seri
dilut
prepar
artifici
ebov
rna
rang
shown
figur
time
posit
detect
rang
min
min
viru
rna
realtim
monitor
thu
rtlamp
detect
limit
np
artifici
rna
reaction
last
min
visual
inspect
posit
reaction
chang
green
neg
one
remain
orang
natur
nm
uv
light
figur
data
indic
sensit
two
detect
method
detect
limit
realtim
rtpcr
np
achiev
higher
ct
valu
ct
thu
conclud
sensit
rtlamp
assay
ebov
similar
higher
realtim
rtpcr
clinic
blood
swab
sampl
simultan
analyz
rtlamp
realtim
rtpcr
patient
confirm
infect
ebov
test
neg
figur
tabl
higher
ct
valu
ct
record
remain
four
sampl
rtpcr
green
fluoresc
observ
min
rtlamp
indic
low
level
eobv
rna
suggest
patient
monitor
week
hospit
ebola
viru
extrem
high
morbid
mortal
level
human
reemerg
caus
outbreak
western
africa
suspect
probabl
confirm
case
death
report
sierra
leon
oct
accord
ebola
situat
report
although
sever
chemic
agent
vaccin
antibodi
inhibit
spread
ebov
human
anim
effect
therapi
clinic
treatment
scarc
combat
increas
incid
ebov
infect
develop
rtlamp
assay
specif
ebov
diagnosi
use
primer
span
bp
np
sequenc
viral
genom
found
limit
detect
techniqu
compar
realtim
rtpcr
assay
use
liferivertmebov
kit
accord
manufactur
instruct
comparison
limit
detect
rna
molecul
standard
target
nucleoprotein
gene
rtpcr
report
weidmann
et
al
present
work
rtlamp
assay
show
equival
superior
sensit
rtpcr
assay
indic
suffici
sensit
detect
low
copi
number
rna
furthermor
rtlamp
assay
show
high
level
specif
crossreact
speci
ebov
virus
also
compar
realtim
rtpcr
confirm
case
ebov
infect
clinic
sampl
rtlamp
assay
detect
presenc
viru
singl
step
revers
transcript
dna
amplif
proceed
singl
tube
constant
temperatur
compar
rtpcr
sensit
rtlamp
assay
far
greater
presenc
inhibitor
moreov
rtlamp
primer
specif
recogn
target
sequenc
use
five
independ
target
sequenc
region
compar
rtpcr
primer
recogn
two
independ
region
therefor
rtlamp
assay
suitabl
rapid
detect
np
clinic
sampl
establish
rapid
effect
visual
rtlamp
assay
target
ebov
np
show
extrem
specif
sensit
molecular
diagnosi
ebov
infect
reliabl
tool
identif
ebov
could
use
altern
method
diagnost
test
clinic
laboratori
without
need
special
apparatu
moreov
provid
accur
result
within
h
may
use
clinic
diagnosi
ebov
develop
countri
jy
xz
conceiv
design
experi
xw
wl
perform
clinic
detect
sierra
leon
hl
pl
dd
perform
develop
rtlamp
xy
el
pl
dd
dz
lc
xh
perform
experi
xz
wrote
manuscript
jy
xz
edit
manuscript
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
